SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-124000
Filing Date
2023-12-06
Accepted
2023-12-06 16:31:38
Documents
14
Period of Report
2023-11-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tm2332309d1_8k.htm   iXBRL 8-K 35497
2 EXHIBIT 10.1 tm2332309d1_ex10-1.htm EX-10.1 216851
  Complete submission text file 0001104659-23-124000.txt   515818

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zura-20231130.xsd EX-101.SCH 3495
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zura-20231130_def.xml EX-101.DEF 26908
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20231130_lab.xml EX-101.LAB 36974
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20231130_pre.xml EX-101.PRE 25532
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2332309d1_8k_htm.xml XML 5078
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 231469990
SIC: 2836 Biological Products, (No Diagnostic Substances)